|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | G01N 33/50 | |
| G01N 33/574 |
| (11) | Patento numeris | 3215844 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15794313.5 |
| Europos patento paraiškos padavimo data | 2015-08-19 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-09-13 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-04-28 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IL2015/050837 |
| Data | 2015-08-19 |
| (87) | Numeris | WO 2016/027273 |
| Data | 2016-02-25 |
| (30) | Numeris | Data | Šalis |
| 201462039156 P | 2014-08-19 | US | |
| 201462079018 P | 2014-11-13 | US |
| (72) |
BANIYASH, Michal, IL
LOTEM, Michal, IL
SADE-FELDMAN, Moshe, IL
KANTERMAN, Julia, IL
|
| (73) |
Hadasit Medical Research Services and Development Ltd.,
Kiryat Hadassah P.O. Box 12000, 9112001 Jerusalem,
IL
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Hi Tech Park Edmond J. Safra Campus Givat Ram, 9139002 Jerusalem, IL |
| (54) | METHODS FOR PREDICTING AND MONITORING CANCER PATIENTS` RESPONSE TO TREATMENT BY MEASURING MYELOID DERIVED SUPPRESSOR CELLS (MDSCS) |
| METHODS FOR PREDICTING AND MONITORING CANCER PATIENTS` RESPONSE TO TREATMENT BY MEASURING MYELOID DERIVED SUPPRESSOR CELLS (MDSCS) |